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Abstract: Synthetic polyesters have deeply impacted various biomedical and engineering 
fields, such as tissue scaffolding and therapeutic delivery. Currently, many applications 
involving polyesters are being explored with polymers derived from monomers that are 
endogenous to the human metabolism. Examples of these monomers include glycerol, 
xylitol, sorbitol, and lactic, sebacic, citric, succinic, α-ketoglutaric, and fumaric acids. In 
terms of mechanical versatility, crystallinity, hydrophobicity, and biocompatibility, 
polyesters synthesized partially or completely from these monomers can display a wide 
range of properties. The flexibility in these macromolecular properties allows for materials 
to be tailored according to the needs of a particular application. Along with the presence of 
natural monomers that allows for a high probability of biocompatibility, there is also an 
added benefit that this class of polyesters is more environmentally friendly than many 
other materials used in biomedical engineering. While the selection of monomers may be 
limited by nature, these polymers have produced or have the potential to produce an 
enormous number of successes in vitro and in vivo.  










The human body is a complex network of different tissues and organs that all have specific 
functions. Tissue engineering has emerged as a route for repairing or replacing the injured tissue with 
designed scaffolds when these tissues are damaged and the body cannot heal them [1-3]. Recently, 
research has suggested that scaffolds for tissue engineering should mimic the mechanical properties of 
the natural tissues. Throughout the body, there are many diverse biological materials that demonstrate 
unique sets of mechanical characteristics [4-9]. For example, heart valves, bladder, smooth muscle, 
collagen fibers, and elastin all exhibit mechanical properties that differ over several orders of 
magnitude (Table 1). Therefore, much research has been devoted to designing biocompatible scaffolds 
that extend over a wide range of rigidities, flexibilities, and strengths. One such class of materials that 
has demonstrated this mechanical versatility is polyesters. These polymers are biodegradable and have 
thus gained popularity as potential tissue scaffolds [10,11]. Additionally, polyester elastomers often 
exhibit degradation rates that can be easily tuned to meet the needs of a particular application.  
Table 1. Mechanical properties of some soft tissues and biodegradable tissue scaffolds. 





Bovine elastin 1.1 2 - 4 
Collagen fibers 100 - 50 5 
Knee articular cartilage 2.1-11.8   6,7 
Smooth muscle (relaxed) 0.006 - 300 5 
Smooth muscle 
(contracted) 0.01 - 300 5 
Human bladder 0.25 0.27 0.69 8 
Porcine bladder 0.26 0.32 1.66 8 
Porcine aortic heart valve 6.4 – 44.7 1.4–8.3 48.7–134.8 9 
PGAa 6,900 70 < 3 2,82 
PLLAb 1,200–2,700 28 - 50 6 2,82 
PDLLAc 1,900–2,400 29 - 35 6 2,82 
PCLd 0.21–0.34 20.7 300–500 2 
PTMCe 6.3–6.8 12 - 24 820–831 90 
PLGAf 1.4–2.8 41.4–55.2 3–10 2 
PLCLg 0.192–68.573 0.57–8.55 175–854.4 83-85 
PLTMCh 4–1,900 1 - 53 4–830 88,89,92 
PGSi 0.282 > 0.5 > 267 34,93,94 
PGSAj 0.048 - 1.375 0.054 - 0.498 47.4–170 29,95,96 
PPSk 0.37 - 378.0 0.57 - 17.64 10.90–205.2 97,98 
APSl 2.45 - 4.24 1.33 - 1.69 64–92 99 
PDCm 1.60–13.98 2.93–11.15 117–502 101,108 
PGlSun - - - 118 
PTKo 0.1–657.4 0.2–30.8 22–583 135 
PPFp 0.9–4,500 .05–120 5 -20 138–142 
a– poly(glycolide); b – poly(L-lactide); c – poly(D,L-lactide); d – poly(caprolactone); e – poly(trimethylene carbonate); f – 
poly(lactide-co-glycolide); g – poly(lactide-co-caprolactone); h – poly(lactide-co-trimethylene carbonate); i – poly(glycerol 
sebacate); j – poly(glycerol sebacate acrylate); k – poly(polyol sebacate); l – poly(1,3-diamino-2-hydroxypropane-co-
polyol sebacate); m – poly(diol-co-citrate); n – poly(glycerol succinate); o – poly(triol α-ketoglutarate); o – poly(propylene 
fumarate).  




In the last decade, as synthetic polyester elastomers have become very popular options for soft 
tissue engineering, research has explored a wide range of scaffolds that have mechanical properties 
that match those of the natural tissue [6,7,12–15]. The rigidity and flexibility of an underlying scaffold 
has been shown to enhance cellular behavior and/or tissue viability [16–20]. Within the class of 
polyester scaffolds, many examples of both thermoplastics and thermosets have been synthesized  
[21–30]. When compared to thermoplastic materials, thermosets offer a number of advantages for 
biomedical applications. For example, thermoplastic elastomers often contain crystalline regions, 
which cause heterogeneous degradation and a non-predictable loss of mechanical strength [31,32]. The 
three-dimensional (3D) geometry of a thermoplastic material is also commonly lost during the 
hydrolysis period [33,34]. On the contrary, thermosets can be designed from amorphous precursors, 
allowing for consistent degradation rates and a linear loss of mechanical strength [11,34]. Polyester 
thermosets also often degrade by surface erosion, resulting in the retention of the 3D structure 
throughout the hydrolysis period [34]. 
Synthetic polyester elastomers have been designed to incorporate a wide range of monomers. With 
the requisite of biocompatibility, some polymers have been based on small molecules that are 
endogenous to the human metabolism. Although the use of metabolite monomers is not required for 
biocompatibility, the use of molecules that are normally present in the human metabolism offers a 
route to minimize toxic side effects. Some of these polyesters, during degradation, release molecules 
that the body can resorb, metabolizing them in various physiological pathways. This review will focus 
on novel polyester elastomers composed of at least one monomer endogenous to the human 
metabolism. While examples of thermoplastics are described, this review will focus primarily on 
polyester thermosets. 
Biological Role of Common Polyester Monomers 
Lactic Acid 
During exercise, activity leads to glycogenolysis, the breakdown of glycogen in the muscles, which 
generates ATP as a source of energy [35–39]. Initially, glycolysis results in the production of pyruvate, 
which can enter the Krebs cycle and ultimately produce ATP through the electron transport chain. 
However, as muscular activity continues, a lack of oxygen prevents the use of this pathway. The Krebs 
cycle stalls, causing pyruvate to accumulate. By entering the Cori cycle, pyruvate is converted to 
lactate by lactate dehydrogenase [40–45]. The liver then receives the lactate, converts it to pyruvate, 
which is in turn converted to glucose. 
Glycerol 
Glycerol is essential to multiple vital metabolic pathways inside cells. For example, glycerol forms 
the backbone of many fats, including triglycerides, formed from the condensation of glycerol and three 
fatty acids through ester bonds, and phospholipids, which are composed of a diglyceride, a phosphate 
group, and a polar molecule [46–52]. Most of the fats digested by humans are composed of 
triglycerides, which cannot be absorbed by the duodenum. Pancreatic lipase is able to hydrolyze the 
ester bonds, forming glycerol, fatty acids, monoglycerides, or diglycerides, all of which are much more 




easily absorbed. Phospholipids, on the other hand, are crucial to compartmentalizing the interior of 
cells. With hydrophobic and hydrophilic moieties, these amphiphilic molecules self-assemble to create 
the lipid bilayers that form the majority of cell membranes. 
Glycerol can also take part in glycolysis or gluconeogenesis, depending on cellular conditions [53–
57]. Glycerol kinase is able to phosphorylate glycerol, forming glycerol-3-phosphate. After being 
oxidized, the product is dihydroxyacetone phosphate, which is an isomer of glyceraldehyde-3-
phosphate. During gluconeogenesis, fructose-1,6-bisphosphate can be formed by the condensation of 
glyceraldehyde-3-phosphate and dihydroxyacetone phosphate, eventually leading to the biosynthesis 
of pyruvate and acetyl coenzyme A (CoA). Glyceraldehyde-3-phosphate can also continue through the 
glycolysis metabolic pathway. 
Figure 1. The structures and reactions of the Cori cycle. 
 
Sebacic Acid 
Sebacic acid is an α,ω-diacid that is ten carbons in length. It is a natural intermediate in the 
metabolism of medium- and long-chain α-carboxylic acids [58–61]. In vivo, dicarboxylic acids are 
formed by the ω-oxidation of α-carboxylic acids. Because it is an even-chain diacid, it can be 
completely metabolized to form acetyl (CoA) and succinyl CoA. Acetyl CoA is crucial to the Krebs 
cycle and the formation of isoprenoids, while succinyl CoA is an intermediate in the Krebs cycle and a 
key component of porphyrin biosynthesis. 
Sugar Alcohols 
Sugar alcohols are the reduced form of aldoses and ketoses. They are commonly used as sugar 
substitutes due to their lower caloric content [62–65]. This class of polyols, which includes glycerol, is 
not usually completely absorbed through the small intestine into the blood stream. These properties 
make sugar alcohols a popular sweetener for diabetics due to digestion resulting in a smaller change in 
blood glucose levels when compared to sucrose. Xylulose is converted into xylitol by L-xylulose 




reductase during mammalian carbohydrate metabolism [66–69]. Similarly, sorbitol, the sugar alcohol 
form of glucose, is converted to fructose by sorbitol dehydrogenase [70–73]. 
Citric, Succinic, and α-Ketoglutaric Acids 
Citric acid, succinic acid, and α-ketoglutaric acid (αKA) are key intermediates in the Krebs cycle 
(as known as the citric acid cycle) [74,75]. The Krebs cycle begins with the production of the citrate, 
the deprotonated form of citric acid. Acetyl CoA is hydrolyzed in the presence of oxaloacetate and 
citrate synthase, resulting in citrate. The enzyme aconitase then dehydrates and rehydrates citrate, 
forming isocitrate. Oxidation of isocitrate by isocitrate dehydrogenase produces oxalosuccinate, which 
rapidly degrades into carbon dioxide and αKA. α-Ketoglutarate dehydrogenase then couples αKA to 
acetyl CoA through oxidative decarboxylation, forming succinyl CoA. Succinate is then synthesized 
from the hydrolysis of succinyl CoA by succinyl CoA synthetase. Succinate dehydrogenase then 
converts succinate to fumarate, simultaneously reducing flavin adenine dinucleotide (FAD) to FADH2. 
Fumarate is converted to L-malate, which is oxidized into oxaloacetate. Oxaloacetate is then involved 
in the initial step of the Krebs cycle, the production of citrate. 
Figure 2. The structures and reactions involved in the Krebs cycle. 
 
 
Outside of the Krebs cycle, α-ketoglutarate is also involved in the biosynthesis of amino acids [76–
79]. Through transamination, the amino group of certain amino acids can be transferred to αKA, often 
producing molecules important to other metabolic pathways. For example, when catalyzed by a 
transaminase, alanine and αKA can be converted to glutamate and pyruvate, while aspartate and αKA 
can react to form glutamate and oxaloacetate. 




Polyesters as Tissue Scaffolds 
Poly(D,L-lactide-co-ε-caprolactone) 
The Shin’oka group has published several manuscripts describing their tissue engineering work in 
human patients [80–82]. Motivated by both the negative side effects and reduced growth potential of 
prosthetic materials, they have focused on using biodegradable materials. Initially, a poly(lactide-co-ε-
caprolactone) co-polymer (PLCL) was reinforced with poly(lactide) (PLA) or poly(glycolide) (PGA) 
[83]. PLCL has been used by other groups for tissue engineering, although with much less clinical data 
[84–86]. The devices were designed by fabricating tubular biodegradable scaffolds that can serve as a 
conduit between functional sections of the pulmonary artery. 
Figure 3. Poly(lactide-co-caprolactone) resulting from the ring-opening polymerization of 
the corresponding monomers. 
 
 
Two different cell types were seeded onto the polyester scaffolds. First, segments of saphenous 
veins were surgically removed and used as a source of cells. A week before the surgery, cells were 
added to the scaffold and maintained in culture medium. This surgical option was performed on two 
patients. As a time-sensitive alternative, bone marrow cells (BMCs) were aspirated from the superior 
iliac spine as cardiac surgery began. After seeding BMCs onto scaffolds, the artificial pulmonary 
artery segments were kept in culture medium for 2–4 h before use. After November of 2001, the 
second strategy was used exclusively, due to the fact that culturing vein cells can lend itself to 
infections and an insufficient amount of cells. The strategy involving BMCs was expected to be 
successful because, as previously reported, endothelialization was observed after seeding BMCs onto 
the surface of a synthetic graft in dog models [87,88]. This strategy was applied to 22 patients, with 
chest radiographs showing excellent recovery and no post-operative complications or obstructions 
observed at the area of the implant.  
In fact, follow-up examinations were conducted 490 ± 276 days after the original surgeries [82]. No 
complications such as stenosis, obstruction of autografts, or thrombosis were noticed. In addition, the 
autografts were able to increase in diameter as a function of time. At the time of follow-up, the average 
tube diameter was 110 ± 7% of the original size. These results indicate that this may be an appropriate 
alternative to prosthetic materials in pediatric patients due to the growth potential. This innovative 
work from the Shin’oka research group, including a large amount of clinical data, has demonstrated 
that vascular autografts designed by seeding BMCs onto polyester scaffolds provided an ideal 
alternative to prosthetic materials during cardiac surgery. 
 





The Feijen lab has extensively studied the use of 1,3-trimethylene carbonate (TMC) and D,L-lactide 
(DLLA) as tissue scaffolds [89,90]. Porous and biodegradable scaffolds were prepared from 
amorphous elastomeric co-polymers of TMC and DLLA to be used in heart tissue engineering. While 
poly(TMC) is not an ideal material for tissue scaffolds, TMC-DLLA co-polymers with either 20 or 50 
molar percentage of TMC are completely amorphous and flexible, making them ideal for the 
preparation of scaffolds for soft tissue scaffolds [91]. Using a salt leaching technique, highly porous, 
compression-molded poly(ester carbonate) films were prepared. Adjusting the size of the salt particles 
and the polymer-to-particle weight ratio in the composite preparation controlled the pore size and the 
porosity of the scaffold, respectively. The poly(ester carbonate) films were also observed during 
degradation in PBS at 37 °C. The size of the films and the molecular weight of the polymer chains 
both gradually decreased in a predictable manner. Additionally, the degradation behavior of the non-
porous and the porous scaffolds were very similar, characterized as bulk hydrolysis. Biocompatibility 
was also studied, as these materials are intended for eventual use as heart tissue scaffolds. TMC-DLLA 
materials (1:4 or 1:1 molar ratios) lose their tensile strength in less than five months and are 
completely resorbed in 11 months. Cell seeding indicated that rat cardiomyocytes attach and 
proliferate well on the TMC-DLLA co-polymers. 
Figure 4.  Ring-opening polymerization of D,L-lactide and trimethylene carbonate, 
resulting in poly(TMC-DLLA). 
 
 
After extensive in vitro testing, transparent poly(TMC-DLLA) samples were evaluated in vivo by 
subcutaneous implantation in rats for up to one year [92]. Although water uptake was low (<2%), the 
poly(ester carbonate) films were opaque upon surgical retrieval. Previous studies indicated that the 
integrity of mechanical properties relies on molecular weights of at least 25,000 g/mol [93]. 
Poly(TMC-DLLA) samples underwent a reduction in molecule weight from 230,000 g/mol to  
<20,000 g/mol in 12 weeks, in vivo. Therefore, applications that necessitate the retention of 
mechanical strength or rigidity could only be successful for approximately three months. Promisingly, 
the co-polymer demonstrated excellent tissue tolerance. After surgical insertion, the poly(ester 
carbonate) film caused a sterile inflammatory reaction and a normal foreign body response, similarly 
observed after implantation of other biodegradable polymers. A second foreign body response, related 
to clearance of smaller polymer fragments, was observed that coincided with extensive mass loss. The 
degradation process of poly(TMC-DLLA) was characterized as being autocatalyzed by bulk 
hydrolysis, with preference for esters as opposed to carbonates. In total, these films underwent a 96% 
mass loss in one year. 





Current interest in randomly cross-linked polyester networks is due in large part to the pioneering 
work of Dr. Robert Langer [94]. In 2002, the design of poly(glycerol sebacate) (PGS), a polyester that 
is analogous to vulcanized rubber, was described. By heating glycerol and sebacic acid for several 
days, the alcohols and acids reacted to form esters. The pre-polymer form of PGS can be melted or 
dissolved for further fabrication processes. The design of PGS was motivated by the need for 
biodegradable materials that are robust in terms of their mechanical properties. It was hypothesized 
that a strong and biocompatible polyester elastomer could be useful to a wide range of biomedical 
applications, including tissue engineering and therapeutic delivery. As mentioned above, glycerol and 
sebacic acid are endogenous to the human metabolism, minimizing the cytotoxic effects due to 
degradation products. PGS achieved a Young’s modulus, an ultimate tensile stress (UTS), and a 
rupture strain of 0.282 MPa, >0.5 MPa, and >267%, respectively. In vitro biocompatibility was also 
assessed by seeding fibroblasts onto PGS-coated glass petri dishes. Cells proliferated well, with 
normal morphologies, when compared to PLGA as a positive control. In vivo testing was then 
performed by subcutaneously implanting PGS films in rats. Based on inflammatory response and the 
formation of fibrous capsules, PGS implants have less negative physiological consequences than 
similar PLGA implants. Also, subcutaneous PGS implants were undetectable after 60 days, having 
been completely resorbed by the rats with no scarring or permanent deformation to the histological 
structure. 




A critical aspect of implanted biodegradable materials is how the geometry and mechanical 
properties of the material change during hydrolysis. PGS was studied throughout the course of in vivo 
degradation in order to determine the timescale during which PGS could be useful [34]. Throughout 
the 35-day study, PGS segments maintained their overall geometry; PLGA implants, however, were 
significantly distorted within 14 days. This observation was further characterized by using SEM to 
visualize the surfaces of PGS and PLGA after implantation. PGS films had similar surface topologies 
at all time points during the study, while holes and cracks continually developed in PLGA elastomers. 
The rate of mass loss is also important because mass loss and mechanical integrity are linked. PGS 
demonstrated a linear rate of mass loss and a linear rate of mechanical strength loss. PLGA samples 
experienced a dramatic loss in mechanical strength by day 7 and in mass by day 21. These findings are 
most likely explained by different degradation mechanisms for PGS (surface erosion) and PLGA (bulk 
degradation). The preliminary results indicate that PGS will be a successful biomaterial, with many in 
vivo applications. 




Recently, PGS was used to create scaffolds for myocardial tissue engineering [95]. Designing grafts 
for myocardial repair has been difficult due to the need to recreate cardiac anisotropy. The vast 
majority of previously explored materials have been incompatible with the formation of a truly 
biomimetic system. Taking inspiration from natural collagen fibers that form a honeycomb-like 
scaffold for cardiac muscle fibers, Engelmayr et al. fabricated similar structures composed of PGS. 
Upon mechanical testing, the stress-strain relationships in the preferred and the cross-preferred 
directions demonstrated that the films behaved in an anisotropic manner. Further studies were carried 
out to determine whether PGS honeycomb scaffolds could potentially be used in vivo by comparing 
the flexibility and rigidity of PGS to those of adult rat, right ventricular myocardium. It was 
determined that both the microfabricated PGS and the natural rat tissue show anisotropic behavior, 
with similar stress-strain relationships. After simulating physiological loading in a fatigue bath and 
determining the effect of in vitro cell culturing on the anisotropy, PGS honeycomb-like scaffolds were 
found to be promising, but not yet ideal, materials for myocardial repair. In addition, neonatal rat heart 
cells, after seeding, oriented in the preferred direction without any external stimuli; this phenomenon is 
not observed as frequently in isotropic scaffolds. Finally, heart cell contractility could be induced by 
stimulation with an electric field with directionally dependent electrical excitation thresholds. After 
conducting their preliminary study, the Langer research group believes that PGS honeycomb-like 
scaffolds offer a path that can lead to functional myocardium repair through tissue engineering. 
Poly(glycerol sebacate acrylate) 
One limitation to the PGS system is that long-term thermal curing could limit encapsulation or 
application. In an attempt to overcome this challenge, Nijst et al. described the design of a photo-
curable PGS with tunable mechanical properties and degradation rates [29,96]. By deprotonating free 
hydroxyl groups and appending acrylate groups, irradiation with UV light yielded elastomeric 
networks. Additionally, by varying the degree of acrylation, relative to the molar equivalents of free 
alcohols in the PGS pre-polymer, the mechanical characteristics and degradation rates of the resulting 
materials could be finely tuned. The Young’s modulus, UTS, and rupture strain ranged  
from 0.05 to 1.38 MPa, 0.05 to 0.50 MPa, and 47 to 170%, respectively. Interestingly, the PGSA pre-
polymer could be combined with other acrylated molecules, offering extended control of 
macromolecular properties. The co-polymerization of PEG-diacrylate with PGSA enabled further 
control of characteristics such as mechanical strength, water swelling, hydrophobicity, and degradation 
rates. In vitro biocompatibility was determined by observing adhesion and proliferation of primary 
human foreskin fibroblasts on different PGSA films. 








The Langer research group very quickly found a practical and inventive application for the photo-
curable PGSA. There is a need for strong biodegradable adhesives that can remain attached to tissue 
while not undergoing permanent deformation when faced with stress. Such a material could be used to 
replace sutures and staples or to aid in the treatment of ulcers and burns. There seemed to be great 
potential for PGSA in this regard due to its biocompatibility and the ability to tune its macromolecular 
properties. In order to design a biodegradable adhesive, Mahdavi et al. drew inspiration from the 
gecko’s ability to adhere to vertical and inverted surfaces [97]. Much research has observed that this 
phenomenon is based on the micro- and nano-textured feet of geckos, and many examples of gecko-
based adhesives have been previously described for material purposes. However, by transferring 
micro- and nano-scale features to PGSA from etched silicon wafers, gecko-like adhesive tapes aimed 
at biomedical applications were fabricated. In order to allow the embossed PGSA films to irreversibly 
bond to tissues in wet conditions (as would be needed in vivo), the PGSA surface was functionalized 
with a carbohydrate-based coating. Oxidized dextran was chosen due to the presence of aldehydes, 
which serve two purposes: (1) free alcohols can react with oxidized dextran to form hemiacetals, 
creating a covalent anchor between the carbohydrate chains and PGSA and (2) aldehydes can also 
react with amines, ubiquitous in biological materials, to form imines, allowing for covalent linkages 
between the “glue” and tissues. The resulting adhesives combine the bonding forces of gecko feet and 
covalent bonds.  
As a proof-of-concept, the covalent modification of amine-functionalized glass with oxidized 
dextran was tested. X-ray photoelectron spectroscopy of the surfaces verified the formation of imine 
bonds. Additionally, after allowing the carbohydrate derivative and the amine-modified glass to react, 
the oxidized dextran could not be removed by rinsing the surface. Non-oxidized dextran could be 
completely removed from the surface in a similar experiment, demonstrating the role of the aldehydes 
groups in immobilization. Furthermore, both in vitro and in vivo adhesion to tissue was studied. In 
addition to being biocompatible, the embossed PGSA films that were coated in oxidized dextran 
demonstrated significantly more adhesion than flat surfaces and films that were not coated with 
oxidized dextran. Additionally, tissue adhesion could be optimized by varying the dimensions of the 
features on the embossed PGSA films, allowing for another level of control over interfacial adhesion. 
Aiming to surpass the initial success of this preliminary investigation, current research is attempting to 
design materials for organ-specific applications that may be able to delivery drugs in addition to acting 
as an adhesive. 
Poly(polyol sebacate) 
Sebacic acid has also been polymerized with various sugar alcohols containing at least four 
hydroxyl groups, allowing for further control of the macromolecular properties of materials based on 
sebacic acid [98,99]. While all of the sugar alcohols are non-toxic, two of these polyols (xylitol and 
sorbitol) are endogenous to the human metabolism. Sugar alcohols are ideal for thermal 
polycondensation because, upon heating or melting, they do not brown the way that sugars can. The 
polymerization strategy was very similar to the above-mentioned polyester thermosets. Two different 
poly(xylitol sebacate) (PXS) materials were synthesized, with xylitol-to-sebacic-acid molar ratios of 
1:1 and 1:2. By altering the equivalents of the diacid, the mechanical and physical properties could be 




tuned. For PXS 1:1 [2:1], the Young’s modulus, UTS, and rupture strain was 0.82 MPa [5.33 MPa], 
0.61 MPa [1.43 MPa], and 205% [33%], respectively. Additionally, the water swelling of these 
polymers could also be altered, with values of 5.1% for the 1:1 material and 1.7% for the 2:1 polyester. 
Both stoichiometric monomer ratios yielded elastomers that exhibited both in vitro and in vivo 
biocompatibility, relative to PLGA. After subcutaneous implantation, PXS 1:1 fully degraded in seven 
weeks, while ~ 75% of PXS 1:2 remained after 28 weeks. 
Figure 7. Synthesis of poly(polyol sebacate) using the sugar alcohols xylitol and sorbitol. 
 
 
By replacing xylitol with sorbitol, the synthesis of poly(sorbitol sebacate) (PSS) was easily 
achieved [99]. Rather than simply altering the molar ratio of the monomers to tune the mechanical 
characteristics of the elastomers, the curing conditions were also varied. PSS 1:1 was cured at 120 °C, 
2 Pa, for 4 d while PSS 1:2 was cross-linked at 120 °C, 2 Pa, for 5 d. The former demonstrated a 
Young’s modulus of 0.37 MPa, a UTS of 0.57 MPa, and a rupture strain of 192%. By increasing the 
molar equivalents of sebacic acid, the mechanical properties were increased, similar to PXS. PSS 1:2 
had a Young’s modulus of 2.67 MPa, a UTS of 1.16 MPa, and a rupture strain of 66%. During a  
15-week in vitro degradation study (PBS, 37 °C), PSS 1:1 and 1:2 lost approximately 15% and 5% of 
their original mass, respectively. Similar to the previously described materials, PSS 1:1 and 1:2 had 
acceptable biocompatibility (compared to PLGA standards) based on in vitro cell seeding and in vivo 
implantation, suggesting poly(polyol sebacate) as a promising class of polyester elastomers for 
biomedical applications. 
Poly(amino alcohol sebacate) 
After designing PGS and PGSA, the Langer research group focused on making elastomeric 
materials that exhibited longer in vivo degradation rates. This goal was accomplished by including 
hydrolytically stable amide bonds throughout the polyester matrix [100]. The thermal 
polycondensation of sebacic acid, 1,3-diamino-2-hydroxypropane, and either glycerol or D,L-threitol 
led to the synthesis of poly(1,3-diamino-2-hydroxypropane–co–polyol sebacate) (APS) composed of 
four non-toxic monomers [101]. The Young’s moduli, UTS, and rupture strain range  
from 1.45–4.34 MPa, 0.24–1.69 MPa, and 21–92%, respectively. Additionally, in vitro degradation 
studies were conducted in a sodium acetate buffer with a pH of 5.2. After incubating in the degradation 
solutions, APS materials demonstrated hydrolytic degradation of 42.8%–97.0%. In addition to 
extended degradation profiles, post-polymerization modifications could potentially be achieved 
through functionalization reactions aimed at the free amines. Overall, these materials were 
biocompatible in an in vitro and an in vivo setting, with projected in vivo degradation half-lives of up 




to 20 months. In terms of macrophage concentration and fibrous capsule formation observed in 
subcutaneous implants, APS demonstrated milder foreign body response than PLGA. 




In order to create polyester elastomers, the research group of Dr. Guillermo Ameer found an ideal 
tri-functional monomer in the Krebs cycle. Rather than using a diacid with polyols, the cardinal 
publication from Dr. Ameer’s group demonstrated polyester elastomers based on citric acid, which 
includes three acid groups and one alcohol [102,103]. Initially, these materials were synthesized 
through thermal polycondensation with aliphatic diols: 1,6-hexanediol, 1,8-octanediol, 1,10-
decanediol, and 1,12-dodecanediol. While several diols were tested, Dr. Ameer’s group focused on 
poly(1,8-octane citrate) (POC). Using an easy fabrication process, non-toxic monomers, and a curing 
technique that allows for facile tuning of physical and mechanical properties, inexpensive materials 
that have amazing potential in soft tissue engineering were designed. The curing process simply 
involves heating the pre-polymer solution, similar to PGS. However, POC was able to form insoluble 
elastomers at temperatures as low as 37 °C. By adjusting the curing temperature and duration, POC 
can obtain Young’s moduli ranging from 0.92 MPa to 16.4 MPa, ultimate tensile strengths up to 6.1 
MPa, and a maximum of 502% elongation at break. The Young’s modulus and ultimate tensile stress 
compare well to elastin from bovine ligaments (1.1 MPa and 2 MPa, respectively).  
The applications of POC have been directed towards cardiovascular tissue engineering. 
Accordingly, the biocompatibility of these materials was evaluated with human aortic smooth muscle 
cells (HASMCs) and human aortic endothelial cells (HAECs). When compared to the non-toxic 
poly(L-lactide) (PLLA), POC films are biocompatible with both cell populations. Finally, the in vivo 
reaction of Sprague-Dawley rates to implanted POC films was determined to be excellent; no chronic 
inflammatory response was observed. Additionally, various types of scaffolds were designed to 
explore their fabrication potential of POC. The resulting constructs were soft and able to fully recover 
from deformation. One example of these scaffolds, a biphasic and tubular structure with a non-porous, 
skin-like interior and a porous exterior, has been used extensively in blood vessel engineering. 




Figure 9. Synthesis of poly(diol-co-citrate) from citric acid and aliphatic diols. 
 
 
In order to determine whether or not the biphasic tubular POC scaffolds would be appropriate 
candidates for in vivo applications, several basic characteristics were studied, including mechanical 
properties and biocompatibility [104]. By first observing the implantable poly(diol-co-citrate) (PDC) 
scaffolds in vitro and in vivo, potential surgical problems, including compliance mismatch and 
thrombosis, could be identified and circumvented. It was determined that the mechanical 
characteristics of the PDC scaffolds match those of native blood vessels well [105]. Varying the diol 
and the curing conditions, the mechanical properties could easily be tuned. These tubular constructs 
were able to achieve Young’s moduli of ~1.5 MPa, ultimate tensile stress of ~3 MPa, and rupture 
elongation of ~350%. Additionally, testing determined the biphasic scaffolds to have a compressive 
modulus of 0.152 MPa, rendering the materials soft and able to fully recover from deformation. Burst 
pressure and compliance values (>120 mmHg and 12.7%, respectively) also offer PDC hybrid 
scaffolds as potential synthetic blood vessels. 
In vitro testing determined that these materials are biocompatible. Importantly, different types of 
cells could be seeded to different areas of the scaffold. HASMCs were seeded to the porous exterior 
phase, while HAECs were cultured on the skin-like, non-porous interior of the artificial blood vessel. 
This compartmentalization of cells may enable the design of blood vessel scaffolds that very 
accurately mimic the local environment of native vessels [106]. Finally, in vivo biocompatibility was 
also used to fully understand the biomedical potential of biphasic PDC constructs. Subcutaneously 
implantation of scaffolds demonstrated significant tissue ingrowth and a foreign body response similar 
to that of PLLA. 
The Ameer group furthered their work in in vivo vascular tissue engineering by making hybrid 
materials of POC and expanded polytetrafluoroethylene (ePTFE) [107]. The current standard-of-care 
for vascular grafts involves either ePTFE or surface modified ePTFE tubes. While this strategy has 
proven effective for large-diameter blood vessel applications (>6 mm diameter), ePTFE small-
diameter blood vessels have performed less successfully due to complications, including graft 
occlusion due to blood clots [108,109]. The surface of ePTFE is inherently thrombogenic and the 
hydrophobic surface can reduce the efficiency with which an endothelial layer of cells can form 
[108,110,111]. Currently, efforts to minimize thrombosis by enhancing endothelialization has 
primarily focused on graft coatings, the conjugation of biomolecules, or the immobilization of non-
degradable polymers. This process, however, introduces possible coating-based complications due to 
compliance, biological response, cost, and long-term efficacy.  
Based on the previously described success of bi-phasic tubular POC scaffolds, the Ameer group 
demonstrated that their polyester acts as a suitable coating for ePTFE vascular grafts. The 
biocompatibility of the implant was improved without negatively affecting compliance. Additionally, 




POC-ePTFE grafts caused reduced platelet adhesion, aggregation, and activation, when compared to 
control ePTFE grafts. To conclude the study of POC-ePTFE grafts, in vivo testing was performed to 
allow access to surgically relevant data. Both the number of macrophages present and the thickness of 
the fibrin coagulum were significantly reduced for the POC-ePTFE graft when compared to the ePTFE 
control. Collectively, the finding indicated that POC has a very promising future in surgical repair of 
blood vessel. 
In order to further understand the potential of POC in vascular surgery, fully biodegradable vascular 
scaffolds were prepared [112]. When compared to the previous study, the difference is that that ePTFE 
graft was replaced with a non-porous POC tube, creating a graft fabricated fully from the polyester. 
Initially, platelet adhesion and activation was studied on glass, ePFTE, PLGA, and POC. Not only do 
fewer platelets attach to POC than any of the other materials, the morphology of the platelets is very 
spherical. When platelets attach to a surface and adopt extended, spread morphologies, the biological 
result is aggregation and activation, which leads to clotting [113,114]. The anti-thrombogenic 
properties of the completely degradable POC graft make it an excellent candidate for blood vessel 
repair. Also, the plasma recalcification kinetics are significantly lower for POC, relative to the other 
materials. The coagulative properties of POC are much more suitable for contact with blood than tissue 
culture plastic and PLGA. Another critical biological process that affects implants is the inflammatory 
response. In order to monitor the inflammatory response of POC in vitro, the activation of human 
THP-1 cells (an alternative to problematic peripheral blood monocytes) was monitored based on 
changes in the level of IL-1β and TNF-α [115,116]. All of the materials, including POC, cause THP-1 
cells to produce very low levels of activation markers, when compared to the positive control 
(lipopolysaccharide). Relative to positive controls, POC had satisfactory hemolysis and protein 
adsorption values, comparable to PLGA, ePTFE, and tissue culture plastic. Finally, HAECs were 
seeded onto POC scaffolds under flowing conditions. While approximately 100% cells attached to 
glass surfaces, only 69% were retained on POC constructs. However, while cell attachment values 
were non-ideal, over half of HAECs were able to remain on POC under physiological shear stress 
conditions, a promising property. All of the above results are encouraging, suggesting that POC is an 
excellent polyester candidate for in vivo vascular tissue engineering. 
Dendritic Poly(glycerol succinate) 
The majority of the previously described research has all focused on randomly cross-linked 
polyester elastomers. However, other classes of polyester tissue scaffolds have also been studied [117]. 
For example, the Grinstaff lab has designed biodegradable dendrimers composed of succinic acid and 
glycerol moieties [118-120]. The materials are entirely composed of natural human metabolites and, 
therefore, complete hydrolytic degradation should not lead to the production of any toxic compounds. 
By using benzylidene acetal protecting groups, stepwise synthesis led to the design of monodisperse 
dendrimers (PDI = 1.02) where the terminal functionality could be controlled (either acids or 
alcohols). The degradation kinetics were tuned according to hydrophobicity of the monomers, the 
dendrimer generation, and the inherent reactivity of the materials.  




Figure 10. Design of dendrimers composed of succinic acid and glycerol. 
 
 
In order to create appropriate materials for tissue engineering, photo-crosslinkable dendrimers were 
designed by appending methacrylate moieties to the terminal alcohols. The Grinstaff group has utilized 
their materials to repair corneal wounds that are usually repaired with sutures. Due to drawbacks 
related to suturing, research in the Grinstaff lab has focused on the delivery and curing of liquid pre-
polymers to seal corneal wounds in situ. The medical adhesive that has been characterized most fully 
is similar to the product shown in Figure 10, except that the core is based on poly(ethylene glycol) 
(PEG) instead of succinic acid. A first generation, methacrylated dendrimer was delivered to a corneal 
laceration and cross-linked so that the leak pressure could be determined. Standard nylon sutures 
obtain a leak pressure 90 mm Hg, while the photo-cured polyester could withstand pressures of up to 
171 mmHg. Both of these values are well above the physiological intraocular pressure of  
15-20 mmHg [121]. In addition to having a larger leak pressure, the dendrimer adhesive, without 
causing additional trauma, allows for a recovery period that is five times faster than recovery from 
sutures. 
In addition to repairing corneal lacerations, the Grinstaff lab has used their photo-curable polyester 
dendrimers to secure laser-assisted in situ keratomileusis (LASIK) flaps [122]. LASIK is the popular 
surgical procedure that corrects myopia and astigmatism by moving a corneal flap, using a laser to 
ablate the cornea stromal tissue, and repositioning the corneal flap. Commonly, sutures are used to 
secure the LASIK flaps during the recovery period. However, as previously stated, sutures are not the 
ideal method for this procedure due to the extra trauma that is inflicted upon the corneal tissue. Using 




donated human eyes, the LASIK flap was secured by curing the PEG-based dendrimer with an argon 
laser. After cross-linking the adhesive, the flaps were manually tested to see the strength of the seal. 
Despite considerable force, the dendrimer seal remained intact. Although these results are qualitative, 
the poly(glycerol succinate) dendrimers have a large amount of potential dealing with surgical 
procedures focusing on cornea repair. 
Poly[tetra(ethylene glycol) α-ketoglutarate] 
Another metabolite from the Krebs cycle, αKA, was the focus of research in 2008 from the Yousaf 
group [123]. Combining αKA and tetra(ethylene glycol), linear polyketoester chains were 
biocatalytically synthesized with Lipase B (from Candida antarctica), an enzyme that is able to 
withstand the high temperatures needed for polycondensation (Figure 8) [124]. Selecting an ethylene 
glycol oligomer as the diol resulted in completely amorphous polymer chains. However, the location 
of the ketone immediately adjacent to the acid in αKA leads to formation of very short polyester 
chains. Molecular weights of Mn = 1,200 g/mol were the largest that could be achieved. Also, αKA is 
incompatible with metal catalysts that are commonly used for polyester synthesis.  
Figure 11.  Synthesis of chemoselective elastomers based on α-ketoglutaric acid and 
tetra(ethylene glycol). Oxime formation occurs from the reaction of the ketone-containing 
materials with oxyamine-terminated ligands.  
 
 
The presence of a ketone in the repeat unit allow for chemoselective immobilization of oxyamine-
containing molecules. Oxime formation is fast, very specific, compatible with organic or aqueous 
environments, hydrolytically stable, and proceeds at physiological conditions [125-130]. These 
characteristics make the reaction between ketones and oxyamines an ideal strategy for the modification 




of biomaterials. This immobilization strategy was especially attractive because of how easily 
oxyamines can be introduced into an extremely wide range of materials, such as carbohydrates, 
peptides, proteins, pseudo-lipids, and therapeutic agents [130]. 
In order to create polyketoester elastomers, the linear chains were capped with methacrylate groups, 
allowing for photo-initiated curing. After cross-linking with UV light, the resulting films were 
biologically inert due to the high content of tetra(ethylene glycol) moieties [131,132]. Without further 
modification, cells were unable to attach to the polyketoester films. However, upon reaction with an 
oxyamine-terminated RGD peptide (the minimal amino acid sequence required to interact with 
integrins, a family of cell surface receptors), cells were able to attach, proliferate, and migrate 
[133,134]. While receiving promising results with poly[tetra(ethylene glycol) α-ketoglutarate], the 
authors decided to progress to randomly cross-linked polyester elastomers based on αKA similar to 
those described above. 
Poly(triol α-ketoglutarate) 
Thermal polycondensation has also been used to achieve elastomeric films from αKA. Previously 
reported, polymerization of α-ketoglutaric acid and one of three triols (glycerol, 1,2,4-butanetriol, or 
1,2,6-hexanetriol) led to the synthesis of poly(triol α-ketoglutarate) (PTK), polyester thermosets that 
contain ketones [135]. Varying the triol, the curing temperature, and/or the duration of the curing 
process allowed for a wide range of mechanical properties and degradation rates. The values of the 
Young’s modulus (0.1–657.4 MPa), ultimate stress (0.2–30.8 MPa), and ultimate strain (22–583%) 
encompass the mechanical properties of many biological materials, increasing the probability of 
success for the use of poly(triol α-ketoglutarate) as a biomaterial [10,11]. Additionally, the PTK series 
hydrolytically degraded in as fast as two days and as long as 28 days in phosphate-buffered saline 
solutions at 37 °C. In general, all of the PTK series degrades very rapidly. This occurs due to the 
presence of the ketone immediately adjacent to an ester. Acting as an electron-withdrawing group, the 
ketone increases the reactivity of the ester carbon, rendering it more susceptible to hydrolysis. 
For post-polymerization modifications, the repeat units contain ketones, which are capable of 
reacting with a variety of oxyamine-terminated molecules to generate stable oxime linkages. To 
demonstrate oxime formation, a solution of an oxyamine-modified dye was flowed through a 
microfluidic cassette onto the surface of PTK films [135]. After rinsing the polyketoester film, the 
pattern is clearly visible using fluorescence microscopy. Oxyamine-conjugation will be used in the 
future to design tissue scaffolds that are functionalized with biologically relevant ligands. 
Finally, as future applications will focus on the biomedical fields, the biocompatibility of 
poly(glycerol α-ketoglutarate) (PGK), poly(1,2,4-butanetriol α-ketoglutarate) (PBK), and poly(1,2,6-
hexanetriol α-ketoglutarate) (PHK) was studied. As all three materials contain the metabolite αKA, 
the cytotoxicity was expected to be low. Based on cell proliferation and morphology, all materials 
were deemed biocompatible. 
Because the PTK series of polyester elastomers degrades rapidly in PBS at 37 °C, we believed that 
dilute solutions of NaOH could cause accelerated hydrolysis [136]. After observing that this 
hypothesis was correct, local degradation was harnessed by using microfluidics. The delivery of NaOH 
solutions in micro-channels caused controlled hydrolysis that led to the formation of etched features. 




This technique is very straightforward, flexible, and inexpensive. Because the polymers are made from 
αKA, a ketone is present in the repeat unit. Microfluidics can also be used to deliver oxyamine-
containing ligands in a controlled manner. As etching and functionalization are compatible with one 
another, we were also able to create functionalized micro-channels in the PTK films. Finally, by 
sealing an etched film to a flat piece of PTK, an enclosed and biodegradable microfluidic system can 
be fabricated. This was demonstrated by flowing an ethanolic solution of ink through the device, 
enabling easy visualization of the features within the polyketoester matrix. Future studies aim to create 
these microfluidic devices in order to explore bioreactors and synthetic vasculature. 




Since its introduction a decade ago, poly(propylene fumarate) (PPF) has quickly become a 
commonly studied scaffold material [137]. By basing the design on two resorbable monomers, the 
degradation products of PPF are non-cytotoxic. Similar to many of the materials synthesized from 
ring-opening polymerizations, the macromolecular properties of PPF are very dependant upon the 
methods used for synthesis, cross-linking, and fabrication [138-141]. In order to determine the 
appropriate application towards which PPF should be applied, the in vitro degradation rates were 
studied. So that a wide range of properties could be observed, bulk and different porosity (70% and 
80%) materials were observed. As expected, the hydrolytic degradation rate was a function of both the 
porosity and the size of the initial porogen. The fastest degrading materials had more and larger pores. 
The study lasted 32 weeks, allowing time for substantial hydrolysis to occur. The amount of mass lost 
for PPF degradation ranged from 15 % – 30 %. After noting these degradation rates, the most common 
application for PPF has been tissue engineering of bone. Bone was a logical medium due to the 
hydrophobicity of PPF and the high degree of potential cross-linking with an alkene in each repeat unit. 




Figure 13. Synthesis of poly(propylene fumarate) containing alkenes as cross-linking sites. 
 
 
As bone exists near soft and hard tissues in vivo, PPF was studied in animal models to ensure 
biocompatibility when interacting with both [142]. For the live studies, rabbits were used as the host 
animal. In order to investigate PPF-soft tissue interactions, samples were subcutaneously implanted. 
Photo-cured PPF has great potential in tissue engineering, based on its interactions with soft tissue. A 
fibrous capsule surrounding the scaffolds was noted. However, the thickness of the cellular 
encapsulation decreased with time, implying that the rabbit tissue found the implant and its 
degradation products to be acceptable. The porosity of the PPF films increased with time, which was 
expected due to the surface degradation of the polyester backbone throughout the study. PPF was also 
studied as a bone substitute so that its interactions with hard tissue could be investigated. After 
creating four non-fatal cranial defects in the rabbits, the polyester was inserted. The hard tissue 
response was similar to the interaction of soft tissues with PPF. While the scaffolds were found to 
contain low amounts of bone ingrowth, 40% of the scaffolds exhibited direct bone-implant contact. 
While other materials have performed similarly, PPF may be differentiated due to the minimal 
thickness of the fibrous capsule and the slower degradation rate [143-146]. Based on these results, PPF 
has been considered a promising option for tissue engineering of bone. 
Conclusions 
These materials offer a number of potential applications throughout the biomedical fields. While 
many uses have been researched, the application that has been most extensively studied is 
cardiovascular tissue engineering. The lactide/ε-caprolactone co-polymer has currently produced the 
most success, as it has been clinically applied. Several human patients were given polyester autografts 
with no side effects exhibited. None of the other materials discussed here have progressed as far, in 
terms of in vivo success. However, while the poly(diol-citrate) series has not been applied to human 
models, it has been implanted in animal models for several different studies. Instead of designing 
artificial arteries, the Ameer research group has shown innovative work in the field of blood vessel 
engineering. The unique design of their biphasic scaffold has allowed for compartmentalization of 




different cell types, enabling the fabrication of truly biomimetic scaffolds. Cardiovascular tissue 
engineering has also become a goal of the Langer lab, with the introduction of their honeycomb-like 
films that maintain cardiac anisotropy.  
While tissue scaffolds cardiovascular applications have been most studied, the key observation is 
that a wide range of polyesters can be designed from monomers that are endogenous to the human 
metabolism. The hydrophobicity, biocompatibility, and mechanical properties span a range that 
encompasses the properties of many biological samples. A large number of these polyesters have been 
synthesized in a manner that has focused on maximizing biocompatibility, assuming that cytotoxicity 
would be minimized by using natural metabolites as monomers. Another characteristic that has 
received considerable attention is the relationship between the mechanical properties of the polyester 
and those of the original tissue. By matching the strength and flexibility of the soft tissue, a scaffold 
has the highest probability of success in vivo. To date, the previously described materials based on 
monomers endogenous to the human metabolism have achieved Young’s moduli between 0.048 MPa 
and 657.4 MPa, UTS values between 0.054 MPa and 53.0 MPa, and rupture strain values between 4% 
and 854.4%. Many of these polyesters have been described as biocompatible based on in vitro and/or 
in vivo testing. In the future, as more tissue scaffolds are designed and existing materials are further 
characterized, the probability of successfully using human metabolites to create scaffolds for tissue 
engineering should continue to increase. 
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